)
AVITA Medical (RCEL) investor relations material
AVITA Medical Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business overview and product portfolio
Focuses on acute wound care, targeting burns, trauma, and surgical repair with a portfolio centered on RECELL, a spray-on skin cell product approved by the FDA in 2019.
RECELL is used in most US burn centers and 50-60 trauma centers, with additional products Cohealyx (collagen-based dermal matrix) and PermeaDerm (biosynthetic dressing).
Products can be used individually or as an integrated platform, reducing hospital stays and donor skin requirements.
Clinical data from 6,300 burn patients shows RECELL reduces hospital stays by 36% compared to traditional grafts.
PermeaDerm and Cohealyx offer additional wound care solutions, with unique features like transparency and rapid graft readiness.
Financial performance and cost management
Achieved $10 million in annual cost reductions, transforming the sales team and reducing G&A expenses.
Maintains strong cost discipline, with a 24% year-over-year decrease in expenses and a 40% reduction in cash use from Q2 to Q3.
Gross margins for RECELL are around 84%, though overall margins are expected to decrease as product mix shifts, but gross and operating profits are projected to rise.
Ended Q3 with $23 million in cash and aims for cash flow break-even and profitability in 2026.
2023 revenue guidance is $70–$74 million, with more detailed 2026 guidance to be provided in January.
Market dynamics and growth strategy
Total addressable market (TAM) is $3.5 billion, with current penetration at about 5%.
Market share in burn centers is 15–20%, with significant room for expansion in both burn and trauma centers.
International expansion is pursued via distributors, with RECELL GO approved in the EU and UK, and pending approval in Australia.
Commercial team is re-engaging surgeons post-reimbursement issues to rebuild RECELL order momentum.
Ongoing post-market studies for Cohealyx and PermeaDerm aim to further validate product effectiveness.
Next AVITA Medical earnings date
Next AVITA Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)